CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities in several high-quality stocks...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate...
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the...
Sheldon Cooper | Lightrocket | Getty ImagesCentene said it offered buyouts to some employees on Monday, as the health insurer grapples with higher medical...
Nikolas Kokovlis | Nurphoto | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news...
The U.S. food supply is "not at risk" from the return of the flesh-eating screwworm parasite to Texas, U.S. Department of Agriculture Secretary Brooke...
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder.Now, she says the...
